Overview
A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac
Status:
Completed
Completed
Trial end date:
2020-09-01
2020-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Primary objective: • To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of primary endpoint : Mean change in walking arthritis pain intensity score Secondary objectives: - To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of secondary endpoints. - To assess safety and tolerability of the Ketoprofen compared with Diclofenac based on the nature and frequency of adverse events in treatment groupsPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Handok Inc.Treatments:
Diclofenac
Ketoprofen
Criteria
Inclusion Criteria:- Patients aged 40-75 years
- Compliance to ACR diagnostic criteria of OA of the knee
- Patients with Kellgren-Lawrence grade 1-3
- Index knee pain should be ≥40 mm on VAS (100mm) scale
Exclusion Criteria:
- Intolerance or allergic reactions to the study therapy
- Usage of NSAIDs within 3 days
- Open skin lesions or dermatological conditions at the site of plaster application
- Surgery or major trauma of the index knee within the previous 12 months
- Pregnant or breast-feeding women
- Alcohol addiction, drug addiction or drug abuse in the past